First PREMIER Bank’s AbbVie ABBV Stock Holding History

First PREMIER Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Sell	6,697 -52	-0.8%	-$11.2K	0.27%	70
2026 Q1	$1.47M	Sell	6,749 -20	-0.3%	-$4.44K	0.34%	68
2025 Q4	$1.55M	Buy	6,769 +114	+2%	+$26K	0.35%	64
2025 Q3	$1.54M	Sell	6,655 -25	-0.4%	-$5.09K	0.35%	64
2025 Q2	$1.24M	Sell	6,680 -296	-4%	-$55K	0.3%	72
2025 Q1	$1.46M	Sell	6,976 -50	-0.7%	-$9.72K	0.37%	60
2024 Q4	$1.25M	Sell	7,026 -400	-5%	-$73.5K	0.32%	67
2024 Q3	$1.47M	Buy	7,426 +206	+3%	+$38.4K	0.37%	61
2024 Q2	$1.24M	Hold	7,220	–	–	0.33%	70
2024 Q1	$1.31M	Buy	7,220 +60	+0.8%	+$10.3K	0.35%	64
2023 Q4	$1.11M	Sell	7,160 -250	-3%	-$36.4K	0.31%	71
2023 Q3	$1.1M	Sell	7,410 -580	-7%	-$85.1K	0.34%	63
2023 Q2	$1.08M	Sell	7,990 -2,057	-20%	-$302K	0.31%	63
2023 Q1	$1.6M	Buy	10,047 +231	+2%	+$35.3K	0.47%	53
2022 Q4	$1.59M	Buy	9,816 +420	+4%	+$64.4K	0.48%	53
2022 Q3	$1.26M	Sell	9,396 -40	-0.4%	-$5.74K	0.41%	58
2022 Q2	$1.44M	Sell	9,436 -125	-1%	-$19.1K	0.43%	57
2022 Q1	$1.55M	Buy	9,561 +278	+3%	+$40.4K	0.41%	62
2021 Q4	$1.26M	Buy	9,283 +9	+0.1%	+$1.06K	0.33%	68
2021 Q3	$1M	Buy	9,274 +115	+1%	+$13.1K	0.28%	74
2021 Q2	$1.03M	Buy	9,159 +285	+3%	+$32.1K	0.3%	72
2021 Q1	$960K	Buy	8,874 +650	+8%	+$69.5K	0.34%	70
2020 Q4	$882K	Buy	8,224 +1,676	+26%	+$161K	0.35%	67
2020 Q3	$574K	Hold	6,548	–	–	0.25%	73
2020 Q2	$642K	Sell	6,548 -50	-0.8%	-$4.4K	0.31%	71
2020 Q1	$502K	Buy	6,598 +85	+1%	+$7.24K	0.28%	75
2019 Q4	$577K	Sell	6,513 -1,720	-21%	-$143K	0.27%	79
2019 Q3	$623K	Buy	8,233 +690	+9%	+$47.3K	0.32%	69
2019 Q2	$549K	Buy	7,543 +300	+4%	+$23.6K	0.3%	73
2019 Q1	$583K	Buy	7,243 +2,265	+46%	+$185K	0.34%	62
2018 Q4	$459K	Buy	4,978 +248	+5%	+$21.8K	0.3%	69
2018 Q3	$447K	Buy	4,730 +975	+26%	+$92.5K	0.28%	75
2018 Q2	$347K	Hold	3,755	–	–	0.23%	79
2018 Q1	$355K	Sell	3,755 -450	-11%	-$49.4K	0.26%	77
2017 Q4	$407K	Sell	4,205 -470	-10%	-$44.3K	0.28%	71
2017 Q3	$415K	Buy	4,675 +380	+9%	+$28.9K	0.29%	68
2017 Q2	$311K	Buy	4,295 +1,295	+43%	+$87.1K	0.23%	77
2017 Q1	$196K	Buy	3,000 +1,050	+54%	+$66K	0.15%	84
2016 Q4	$122K	Hold	1,950	–	–	0.09%	97
2016 Q3	$123K	Buy	1,950 +1,850	+1,850%	+$120K	0.09%	97
2016 Q2	$6K	Hold	100	–	–	﹤0.01%	159
2016 Q1	$6K	Hold	100	–	–	﹤0.01%	156
2015 Q4	$6K	Buy	+100	New	+$5.76K	0.01%	158

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

First PREMIER Bank's ABBV Position: Q2 2026 in Review

First PREMIER Bank reduced its AbbVie (ABBV) stake by 0.77% in Q2 2026, selling an estimated $11.2K and leaving 6,697 shares worth $1.69M. The position accounts for 0.27% of the portfolio, ranked #70.

First PREMIER Bank first reported a position in ABBV in Q4 2015 and has held it in 43 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

First PREMIER Bank held 6,697 shares of AbbVie worth $1.69M as of Q2 2026.
First PREMIER Bank sold 52 AbbVie shares in Q2 2026, an estimated $11.2K.
AbbVie made up 0.27% of First PREMIER Bank's portfolio in Q2 2026, its #70 holding.
First PREMIER Bank first reported a position in AbbVie in Q4 2015 and has held it in 43 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.